LONDON (Reuters) - AstraZeneca, fighting a $106 billion bid approach from Pfizer, is talking to other companies as it seeks a partnering deal for its experimental Alzheimer's drug. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/npml23p28FE/story01.htm
Read More
No comments:
Post a Comment